BAC
AGN

Boys Arnold & Co’s Allergan plc AGN Stock Holding History

Boys Arnold & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-1,550
Closed -$484K – 213
2015
Q4 		$484K Buy
1,550
+233
+18% +$69.4K 0.05% 199
2015
Q3 		$358K Buy
+1,317
New +$405K 0.07% 179

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Boys Arnold & Co's AGN Position: Q1 2016 in Review

Boys Arnold & Co sold out of Allergan plc (AGN) in Q1 2016, closing a stake of 1,550 shares — an estimated $484K sold.

Boys Arnold & Co first reported a position in AGN in Q3 2015 and held it in 2 quarters. The position peaked at $484K in Q4 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

  • Boys Arnold & Co reported no remaining Allergan plc position as of Q1 2016 after selling out during the quarter.
  • Boys Arnold & Co sold 1,550 Allergan plc shares in Q1 2016, an estimated $484K.
  • Boys Arnold & Co first reported a position in Allergan plc in Q3 2015 and held it in 2 quarters.
  • Boys Arnold & Co's Allergan plc position peaked at $484K in Q4 2015.
  • 1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Boys Arnold & Co's 13F filing for Q1 2016, filed 27 Apr 2016.